TransEnterix, a medical device maker using robotics, disclosed early Thursday the sale of a surgery system to the Saitama Medical University International Medical Center in Tokyo, Japan. Shares rose more than 3% in pre-market.
The Senhance robotic surgery system was purchased under a physician import license, which allows medical devices to be directly purchased by Japanese physicians, the company said in a statement. Details of the purchasing price were not announced. “Japan is the second-largest market for medical devices as well as robotic-assisted surgery devices, and has a history of driving innovation in advanced minimally invasive surgery,” said CEO Todd Pope said.